{"transactions":[{"id":1358367,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-11-19T23:26:17.000Z","date":"2024-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":14286,"price":6.175,"value":88216.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":506852,"source":{"system":"sec-edgar","filing":"0001601830-24-000213","document":"wk-form4_1732058770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000213/wk-form4_1732058770.xml","form_type":"4"}},{"id":1380553,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-28T21:25:06.000Z","date":"2024-10-24","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":452000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001601830-24-000181","document":"wk-form4_1730150699.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000181/wk-form4_1730150699.xml","form_type":"4"}},{"id":1380552,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-10-28T21:25:06.000Z","date":"2024-10-24","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":6.3091,"value":37854.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.22 to $6.43 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":521138,"source":{"system":"sec-edgar","filing":"0001601830-24-000181","document":"wk-form4_1730150699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000181/wk-form4_1730150699.xml","form_type":"4"}},{"id":1380551,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-10-28T21:25:06.000Z","date":"2024-10-24","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":1.06,"value":6360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."}],"balance_after":527138,"source":{"system":"sec-edgar","filing":"0001601830-24-000181","document":"wk-form4_1730150699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000181/wk-form4_1730150699.xml","form_type":"4"}},{"id":1397743,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-30T22:15:34.000Z","date":"2024-09-26","kind":"exercise","planned":true,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":458000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001601830-24-000161","document":"wk-form4_1727734527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000161/wk-form4_1727734527.xml","form_type":"4"}},{"id":1397742,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-09-30T22:15:34.000Z","date":"2024-09-26","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":7.0008,"value":42004.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.84 to $7.16 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":521138,"source":{"system":"sec-edgar","filing":"0001601830-24-000161","document":"wk-form4_1727734527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000161/wk-form4_1727734527.xml","form_type":"4"}},{"id":1397741,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-09-30T22:15:34.000Z","date":"2024-09-26","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":1.06,"value":6360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."}],"balance_after":527138,"source":{"system":"sec-edgar","filing":"0001601830-24-000161","document":"wk-form4_1727734527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000161/wk-form4_1727734527.xml","form_type":"4"}},{"id":1417438,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-03T20:48:42.000Z","date":"2024-08-29","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":464000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001601830-24-000150","document":"wk-form4_1725396515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000150/wk-form4_1725396515.xml","form_type":"4"}},{"id":1417437,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-09-03T20:48:42.000Z","date":"2024-08-29","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":7.5627,"value":45376.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.34 to $7.77 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":521138,"source":{"system":"sec-edgar","filing":"0001601830-24-000150","document":"wk-form4_1725396515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000150/wk-form4_1725396515.xml","form_type":"4"}},{"id":1417436,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-09-03T20:48:42.000Z","date":"2024-08-29","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":1.06,"value":6360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."}],"balance_after":527138,"source":{"system":"sec-edgar","filing":"0001601830-24-000150","document":"wk-form4_1725396515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000150/wk-form4_1725396515.xml","form_type":"4"}},{"id":1428819,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-08-19T23:09:53.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":14319,"price":6.69,"value":95794.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":521138,"source":{"system":"sec-edgar","filing":"0001601830-24-000128","document":"wk-form4_1724108986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000128/wk-form4_1724108986.xml","form_type":"4"}},{"id":1447017,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-29T22:16:17.000Z","date":"2024-07-25","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":470000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001601830-24-000105","document":"wk-form4_1722291370.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000105/wk-form4_1722291370.xml","form_type":"4"}},{"id":1447016,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-07-29T22:16:17.000Z","date":"2024-07-25","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":8.1349,"value":48809.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.73 to $8.5. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":535457,"source":{"system":"sec-edgar","filing":"0001601830-24-000105","document":"wk-form4_1722291370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000105/wk-form4_1722291370.xml","form_type":"4"}},{"id":1447015,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-07-29T22:16:17.000Z","date":"2024-07-25","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":1.06,"value":6360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."}],"balance_after":541457,"source":{"system":"sec-edgar","filing":"0001601830-24-000105","document":"wk-form4_1722291370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000105/wk-form4_1722291370.xml","form_type":"4"}},{"id":1466994,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T21:14:06.000Z","date":"2024-06-27","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":476000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001601830-24-000095","document":"wk-form4_1719609240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000095/wk-form4_1719609240.xml","form_type":"4"}},{"id":1466993,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-06-28T21:14:06.000Z","date":"2024-06-27","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":7.215,"value":43290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.91 to $7.575. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":535457,"source":{"system":"sec-edgar","filing":"0001601830-24-000095","document":"wk-form4_1719609240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000095/wk-form4_1719609240.xml","form_type":"4"}},{"id":1466992,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-06-28T21:14:06.000Z","date":"2024-06-27","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":1.06,"value":6360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2024."}],"balance_after":541457,"source":{"system":"sec-edgar","filing":"0001601830-24-000095","document":"wk-form4_1719609240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000095/wk-form4_1719609240.xml","form_type":"4"}},{"id":1494772,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-03T22:31:41.000Z","date":"2024-05-30","kind":"exercise","planned":true,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":482000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001601830-24-000068","document":"wk-form4_1717453891.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000068/wk-form4_1717453891.xml","form_type":"4"}},{"id":1494771,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-06-03T22:31:41.000Z","date":"2024-05-30","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":8.775,"value":26325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.65 to $8.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":535457,"source":{"system":"sec-edgar","filing":"0001601830-24-000068","document":"wk-form4_1717453891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000068/wk-form4_1717453891.xml","form_type":"4"}},{"id":1494770,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-06-03T22:31:41.000Z","date":"2024-05-30","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,224 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2024."}],"balance_after":538457,"source":{"system":"sec-edgar","filing":"0001601830-24-000068","document":"wk-form4_1717453891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000068/wk-form4_1717453891.xml","form_type":"4"}},{"id":1510512,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-05-17T23:12:21.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9998,"price":10.01,"value":100079.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":533233,"source":{"system":"sec-edgar","filing":"0001601830-24-000059","document":"wk-form4_1715987524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000059/wk-form4_1715987524.xml","form_type":"4"}},{"id":1533604,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-29T22:41:22.000Z","date":"2024-04-25","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":485000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001601830-24-000045","document":"wk-form4_1714430473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000045/wk-form4_1714430473.xml","form_type":"4"}},{"id":1533603,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-04-29T22:41:22.000Z","date":"2024-04-25","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.6735,"value":23020.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.5 to $7.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":543231,"source":{"system":"sec-edgar","filing":"0001601830-24-000045","document":"wk-form4_1714430473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000045/wk-form4_1714430473.xml","form_type":"4"}},{"id":1533602,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-04-29T22:41:22.000Z","date":"2024-04-25","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the Reporting Person's last ownership report, she has transferred 96,751 shares of RXRX Class A Common Stock to her former spouse pursuant to a domestic relations order.  The Reporting Person no longer reports as beneficially owned any securities owned by her former spouse."}],"balance_after":546231,"source":{"system":"sec-edgar","filing":"0001601830-24-000045","document":"wk-form4_1714430473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000045/wk-form4_1714430473.xml","form_type":"4"}},{"id":1561691,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-25T22:39:10.000Z","date":"2024-03-21","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":488000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001601830-24-000025","document":"wk-form4_1711406339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000025/wk-form4_1711406339.xml","form_type":"4"}},{"id":1561690,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-03-25T22:39:10.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":610,"price":11.3361,"value":6915.021,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $11.28 to $11.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":639982,"source":{"system":"sec-edgar","filing":"0001601830-24-000025","document":"wk-form4_1711406339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000025/wk-form4_1711406339.xml","form_type":"4"}},{"id":1561689,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-03-25T22:39:10.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":7390,"price":10.6989,"value":79064.871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.28 to $11.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":640592,"source":{"system":"sec-edgar","filing":"0001601830-24-000025","document":"wk-form4_1711406339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000025/wk-form4_1711406339.xml","form_type":"4"}},{"id":1561688,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-03-25T22:39:10.000Z","date":"2024-03-21","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":647982,"source":{"system":"sec-edgar","filing":"0001601830-24-000025","document":"wk-form4_1711406339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000025/wk-form4_1711406339.xml","form_type":"4"}},{"id":1621748,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-24T00:22:51.000Z","date":"2024-02-22","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":496000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001856414-24-000004","document":"wk-form4_1708734159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185641424000004/wk-form4_1708734159.xml","form_type":"4"}},{"id":1621747,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-02-24T00:22:51.000Z","date":"2024-02-22","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":14.895,"value":119160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $14.42 to $15.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":639982,"source":{"system":"sec-edgar","filing":"0001856414-24-000004","document":"wk-form4_1708734159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185641424000004/wk-form4_1708734159.xml","form_type":"4"}},{"id":1621746,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-02-24T00:22:51.000Z","date":"2024-02-22","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":647982,"source":{"system":"sec-edgar","filing":"0001856414-24-000004","document":"wk-form4_1708734159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185641424000004/wk-form4_1708734159.xml","form_type":"4"}},{"id":1637531,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-02-17T00:58:42.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5379,"price":12.43,"value":66860.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":639982,"source":{"system":"sec-edgar","filing":"0001209191-24-003487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003487/doc4.xml","form_type":"4"}},{"id":1645336,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T00:00:36.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":447917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":447917,"derivative":{"exercise_price":10.09,"expiration_date":"2034-02-09","underlying":"Class A Common Stock","underlying_shares":447917},"source":{"system":"sec-edgar","filing":"0001209191-24-003236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003236/doc4.xml","form_type":"4"}},{"id":1645335,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-02-14T00:00:36.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2800,"price":10.09,"value":28252.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":645361,"source":{"system":"sec-edgar","filing":"0001209191-24-003236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003236/doc4.xml","form_type":"4"}},{"id":1645334,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-02-14T00:00:36.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":223958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2024 and every three months thereafter."}],"balance_after":648161,"source":{"system":"sec-edgar","filing":"0001209191-24-003236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003236/doc4.xml","form_type":"4"}},{"id":1645333,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Marriott Tina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-02-14T00:00:36.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":9655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vested immediately upon the grant date."}],"balance_after":424203,"source":{"system":"sec-edgar","filing":"0001209191-24-003236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003236/doc4.xml","form_type":"4"}},{"id":1667929,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-29T23:52:07.000Z","date":"2024-01-25","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":504000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-24-002391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124002391/doc4.xml","form_type":"4"}},{"id":1667928,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-01-29T23:52:07.000Z","date":"2024-01-25","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":10.3452,"value":82761.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.17 to $10.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":414548,"source":{"system":"sec-edgar","filing":"0001209191-24-002391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124002391/doc4.xml","form_type":"4"}},{"id":1667927,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-01-29T23:52:07.000Z","date":"2024-01-25","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":422584,"source":{"system":"sec-edgar","filing":"0001209191-24-002391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124002391/doc4.xml","form_type":"4"}},{"id":1696062,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-02T21:58:49.000Z","date":"2023-12-28","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":512000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-24-000175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124000175/doc4.xml","form_type":"4"}},{"id":1696061,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-01-02T21:58:49.000Z","date":"2023-12-28","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":10.5817,"value":84653.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.34 to $10.75 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":414548,"source":{"system":"sec-edgar","filing":"0001209191-24-000175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124000175/doc4.xml","form_type":"4"}},{"id":1696060,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2024-01-02T21:58:49.000Z","date":"2023-12-28","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,144 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2023."}],"balance_after":422548,"source":{"system":"sec-edgar","filing":"0001209191-24-000175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124000175/doc4.xml","form_type":"4"}},{"id":1736064,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-17T22:53:29.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":520000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-055846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055846/doc4.xml","form_type":"4"}},{"id":1736063,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-11-17T22:53:29.000Z","date":"2023-11-16","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":6.7599,"value":20279.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $6.61 to $7.18 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":413404,"source":{"system":"sec-edgar","filing":"0001209191-23-055846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055846/doc4.xml","form_type":"4"}},{"id":1736062,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-11-17T22:53:29.000Z","date":"2023-11-16","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":416404,"source":{"system":"sec-edgar","filing":"0001209191-23-055846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055846/doc4.xml","form_type":"4"}},{"id":1736061,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-11-17T22:53:29.000Z","date":"2023-11-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":5378,"price":7.18,"value":38614.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":413404,"source":{"system":"sec-edgar","filing":"0001209191-23-055846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055846/doc4.xml","form_type":"4"}},{"id":1753702,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-30T22:26:31.000Z","date":"2023-10-26","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":523000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-053890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123053890/doc4.xml","form_type":"4"}},{"id":1753701,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-10-30T22:26:31.000Z","date":"2023-10-26","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":5.6283,"value":16884.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $5.55 to $5.76 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":418782,"source":{"system":"sec-edgar","filing":"0001209191-23-053890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123053890/doc4.xml","form_type":"4"}},{"id":1753700,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-10-30T22:26:31.000Z","date":"2023-10-26","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":421782,"source":{"system":"sec-edgar","filing":"0001209191-23-053890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123053890/doc4.xml","form_type":"4"}},{"id":1770099,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-02T22:19:48.000Z","date":"2023-09-28","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":526000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-051191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123051191/doc4.xml","form_type":"4"}},{"id":1770098,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-10-02T22:19:48.000Z","date":"2023-09-28","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.7198,"value":23159.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.56 to $7.83 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":418782,"source":{"system":"sec-edgar","filing":"0001209191-23-051191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123051191/doc4.xml","form_type":"4"}},{"id":1770097,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-10-02T22:19:48.000Z","date":"2023-09-28","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":421782,"source":{"system":"sec-edgar","filing":"0001209191-23-051191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123051191/doc4.xml","form_type":"4"}},{"id":1795024,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-28T22:04:18.000Z","date":"2023-08-24","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":529000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-047538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123047538/doc4.xml","form_type":"4"}},{"id":1795023,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-08-28T22:04:18.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":63,"price":9.4532,"value":595.5516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $9.45 to $9.46 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":418782,"source":{"system":"sec-edgar","filing":"0001209191-23-047538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123047538/doc4.xml","form_type":"4"}},{"id":1795022,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-08-28T22:04:18.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":2937,"price":8.639,"value":25372.743,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $8.42 to $9.36 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":418845,"source":{"system":"sec-edgar","filing":"0001209191-23-047538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123047538/doc4.xml","form_type":"4"}},{"id":1795021,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-08-28T22:04:18.000Z","date":"2023-08-24","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":421782,"source":{"system":"sec-edgar","filing":"0001209191-23-047538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123047538/doc4.xml","form_type":"4"}},{"id":1802916,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:41:30.000Z","date":"2023-08-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":5378,"price":9.18,"value":49370.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":418782,"source":{"system":"sec-edgar","filing":"0001209191-23-046426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046426/doc4.xml","form_type":"4"}},{"id":1821350,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-28T21:50:06.000Z","date":"2023-07-29","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":532000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-23-043713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043713/doc4.xml","form_type":"4"}},{"id":1821349,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-07-28T21:50:06.000Z","date":"2023-07-27","kind":"sale","planned":true,"acquired":false,"shares":4373,"price":14.0461,"value":61423.5953,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.77 to $14.30 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":424160,"source":{"system":"sec-edgar","filing":"0001209191-23-043713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043713/doc4.xml","form_type":"4"}},{"id":1821348,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-07-28T21:50:06.000Z","date":"2023-07-27","kind":"sale","planned":true,"acquired":false,"shares":3627,"price":13.1155,"value":47569.9185,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.77 to $13.74 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":428533,"source":{"system":"sec-edgar","filing":"0001209191-23-043713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043713/doc4.xml","form_type":"4"}},{"id":1821347,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-07-28T21:50:06.000Z","date":"2023-07-27","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":432160,"source":{"system":"sec-edgar","filing":"0001209191-23-043713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123043713/doc4.xml","form_type":"4"}},{"id":1839278,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T19:21:22.000Z","date":"2023-06-29","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":540000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-040504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123040504/doc4.xml","form_type":"4"}},{"id":1839277,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-07-03T19:21:22.000Z","date":"2023-06-29","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.49,"value":22470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.38 to $7.74 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":424160,"source":{"system":"sec-edgar","filing":"0001209191-23-040504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123040504/doc4.xml","form_type":"4"}},{"id":1839276,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-07-03T19:21:22.000Z","date":"2023-06-29","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."}],"balance_after":427160,"source":{"system":"sec-edgar","filing":"0001209191-23-040504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123040504/doc4.xml","form_type":"4"}},{"id":1869072,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T22:05:15.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":543000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-033974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123033974/doc4.xml","form_type":"4"}},{"id":1869071,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-06-02T22:05:15.000Z","date":"2023-05-31","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":8.6294,"value":25888.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $8.47 to $9.02 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":424160,"source":{"system":"sec-edgar","filing":"0001209191-23-033974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123033974/doc4.xml","form_type":"4"}},{"id":1869070,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-06-02T22:05:15.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":1.06,"value":3180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,731 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 22, 2023."}],"balance_after":427160,"source":{"system":"sec-edgar","filing":"0001209191-23-033974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123033974/doc4.xml","form_type":"4"}},{"id":1888371,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-05-17T22:19:13.000Z","date":"2023-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5415,"price":5.6,"value":30324.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":422429,"source":{"system":"sec-edgar","filing":"0001209191-23-030375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123030375/doc4.xml","form_type":"4"}},{"id":1989663,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T22:46:40.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":546000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-23-013329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123013329/doc4.xml","form_type":"4"}},{"id":1989662,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-02-27T22:46:40.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":8000,"price":7.8175,"value":62540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.74 to $8.08 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":427844,"source":{"system":"sec-edgar","filing":"0001209191-23-013329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123013329/doc4.xml","form_type":"4"}},{"id":1989661,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-02-27T22:46:40.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":435844,"source":{"system":"sec-edgar","filing":"0001209191-23-013329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123013329/doc4.xml","form_type":"4"}},{"id":2006490,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:16:27.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":1603,"price":8.44,"value":13529.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":427844,"source":{"system":"sec-edgar","filing":"0001209191-23-010781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123010781/doc4.xml","form_type":"4"}},{"id":2032101,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:13:24.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":434122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":434122,"derivative":{"exercise_price":8.55,"expiration_date":"2033-02-01","underlying":"Class A Common Stock","underlying_shares":434122},"source":{"system":"sec-edgar","filing":"0001209191-23-007048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007048/doc4.xml","form_type":"4"}},{"id":2032100,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:13:24.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":3093,"price":8.55,"value":26445.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":429447,"source":{"system":"sec-edgar","filing":"0001209191-23-007048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007048/doc4.xml","form_type":"4"}},{"id":2032099,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:13:24.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":9732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This RSU vested immediately upon the grant date."}],"balance_after":432540,"source":{"system":"sec-edgar","filing":"0001209191-23-007048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007048/doc4.xml","form_type":"4"}},{"id":2032098,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:13:24.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":217061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2023 and every three months thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2093 shares acquired under the Recursion stock purchase plan on May 20, 2022."}],"balance_after":422808,"source":{"system":"sec-edgar","filing":"0001209191-23-007048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123007048/doc4.xml","form_type":"4"}},{"id":2043481,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-27T22:03:18.000Z","date":"2023-01-26","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":554000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-23-005316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123005316/doc4.xml","form_type":"4"}},{"id":2043480,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-01-27T22:03:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":8000,"price":8.0684,"value":64547.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.95 to $8.31 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":203654,"source":{"system":"sec-edgar","filing":"0001209191-23-005316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123005316/doc4.xml","form_type":"4"}},{"id":2043479,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2023-01-27T22:03:18.000Z","date":"2023-01-26","kind":"exercise","acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":211654,"source":{"system":"sec-edgar","filing":"0001209191-23-005316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123005316/doc4.xml","form_type":"4"}},{"id":2074054,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-30T22:01:52.000Z","date":"2022-12-29","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":562000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-22-063013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122063013/doc4.xml","form_type":"4"}},{"id":2074053,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-12-30T22:01:52.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":8000,"price":7.6958,"value":61566.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.28 to $7.89 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":203654,"source":{"system":"sec-edgar","filing":"0001209191-22-063013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122063013/doc4.xml","form_type":"4"}},{"id":2074052,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-12-30T22:01:52.000Z","date":"2022-12-29","kind":"exercise","acquired":true,"shares":8000,"price":1.06,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":211654,"source":{"system":"sec-edgar","filing":"0001209191-22-063013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122063013/doc4.xml","form_type":"4"}},{"id":2111528,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T23:46:38.000Z","date":"2022-11-17","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":570000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-057706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057706/doc4.xml","form_type":"4"}},{"id":2111527,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:46:38.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":16000,"price":10.9626,"value":175401.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.78 to $11.32 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":203654,"source":{"system":"sec-edgar","filing":"0001209191-22-057706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057706/doc4.xml","form_type":"4"}},{"id":2111526,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:46:38.000Z","date":"2022-11-17","kind":"exercise","acquired":true,"shares":16000,"price":1.06,"value":16960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":219654,"source":{"system":"sec-edgar","filing":"0001209191-22-057706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057706/doc4.xml","form_type":"4"}},{"id":2111525,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-11-17T23:46:38.000Z","date":"2022-11-15","kind":"tax_withholding","acquired":false,"shares":1453,"price":11.86,"value":17232.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":203654,"source":{"system":"sec-edgar","filing":"0001209191-22-057706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122057706/doc4.xml","form_type":"4"}},{"id":2130217,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-28T22:07:41.000Z","date":"2022-10-27","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":586000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-054855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122054855/doc4.xml","form_type":"4"}},{"id":2130216,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-10-28T22:07:41.000Z","date":"2022-10-27","kind":"sale","acquired":false,"shares":16000,"price":10.7156,"value":171449.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.35 to $11.13 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":205107,"source":{"system":"sec-edgar","filing":"0001209191-22-054855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122054855/doc4.xml","form_type":"4"}},{"id":2130215,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-10-28T22:07:41.000Z","date":"2022-10-27","kind":"exercise","acquired":true,"shares":16000,"price":1.06,"value":16960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":221107,"source":{"system":"sec-edgar","filing":"0001209191-22-054855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122054855/doc4.xml","form_type":"4"}},{"id":2146960,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-03T23:32:15.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":602000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-051979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122051979/doc4.xml","form_type":"4"}},{"id":2146959,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-10-03T23:32:15.000Z","date":"2022-09-29","kind":"sale","acquired":false,"shares":64,"price":11.53,"value":737.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":205107,"source":{"system":"sec-edgar","filing":"0001209191-22-051979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122051979/doc4.xml","form_type":"4"}},{"id":2146958,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-10-03T23:32:15.000Z","date":"2022-09-29","kind":"sale","acquired":false,"shares":15936,"price":10.8566,"value":173010.7776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.52 to $11.47 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":205171,"source":{"system":"sec-edgar","filing":"0001209191-22-051979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122051979/doc4.xml","form_type":"4"}},{"id":2146957,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-10-03T23:32:15.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":16000,"price":1.06,"value":16960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":221107,"source":{"system":"sec-edgar","filing":"0001209191-22-051979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122051979/doc4.xml","form_type":"4"}},{"id":2180657,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-17T22:34:32.000Z","date":"2022-08-16","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":618000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-046463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046463/doc4.xml","form_type":"4"}},{"id":2180656,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-08-17T22:34:32.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":16000,"price":12.6023,"value":201636.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.06 to $12.96 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":295107,"source":{"system":"sec-edgar","filing":"0001209191-22-046463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046463/doc4.xml","form_type":"4"}},{"id":2180655,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-08-17T22:34:32.000Z","date":"2022-08-16","kind":"exercise","acquired":true,"shares":16000,"price":1.06,"value":16960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":221107,"source":{"system":"sec-edgar","filing":"0001209191-22-046463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046463/doc4.xml","form_type":"4"}},{"id":2180654,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-08-17T22:34:32.000Z","date":"2022-08-15","kind":"tax_withholding","acquired":false,"shares":1453,"price":12.96,"value":18830.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":205107,"source":{"system":"sec-edgar","filing":"0001209191-22-046463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122046463/doc4.xml","form_type":"4"}},{"id":2265167,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-05-18T23:15:30.000Z","date":"2022-05-16","kind":"tax_withholding","acquired":false,"shares":1458,"price":5.67,"value":8266.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":206560,"source":{"system":"sec-edgar","filing":"0001209191-22-030247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122030247/doc4.xml","form_type":"4"}},{"id":2343561,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T01:55:49.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":58500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date."}],"balance_after":634000,"derivative":{"exercise_price":1.06,"expiration_date":"2028-07-22","underlying":"Class A Common Stock","underlying_shares":634000},"source":{"system":"sec-edgar","filing":"0001209191-22-017387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122017387/doc4.xml","form_type":"4"}},{"id":2343560,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85899,"kind":"person","name":"Marriott Tina","position":1,"cik":"0001856414","reported_name":"Larson Tina Marriott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Class A Common Stock","published_at":"2022-03-09T01:55:49.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":58500,"price":1.06,"value":62010.0,"ownership":{"direct":true},"balance_after":208018,"source":{"system":"sec-edgar","filing":"0001209191-22-017387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122017387/doc4.xml","form_type":"4"}}],"next_cursor":"2022-03-09T01:55:49.000000Z,2343560"}